AMRN
Price
$14.60
Change
-$0.33 (-2.21%)
Updated
Sep 17 closing price
Capitalization
308.79M
MGNX
Price
$1.53
Change
+$0.06 (+4.08%)
Updated
Sep 17 closing price
Capitalization
92.91M
54 days until earnings call
Interact to see
Advertisement

AMRN vs MGNX

Header iconAMRN vs MGNX Comparison
Open Charts AMRN vs MGNXBanner chart's image
Amarin
Price$14.60
Change-$0.33 (-2.21%)
Volume$84.76K
Capitalization308.79M
MacroGenics
Price$1.53
Change+$0.06 (+4.08%)
Volume$780.97K
Capitalization92.91M
AMRN vs MGNX Comparison Chart in %
Loading...
AMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRN vs. MGNX commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRN is a Hold and MGNX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 18, 2025
Stock price -- (AMRN: $14.60 vs. MGNX: $1.53)
Brand notoriety: AMRN: Notable vs. MGNX: Not notable
AMRN represents the Pharmaceuticals: Major, while MGNX is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMRN: 131% vs. MGNX: 100%
Market capitalization -- AMRN: $308.79M vs. MGNX: $92.91M
AMRN [@Pharmaceuticals: Major] is valued at $308.79M. MGNX’s [@Biotechnology] market capitalization is $92.91M. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $685.53B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $100.34B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $88.9B. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRN’s FA Score shows that 0 FA rating(s) are green whileMGNX’s FA Score has 0 green FA rating(s).

  • AMRN’s FA Score: 0 green, 5 red.
  • MGNX’s FA Score: 0 green, 5 red.
According to our system of comparison, AMRN is a better buy in the long-term than MGNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRN’s TA Score shows that 2 TA indicator(s) are bullish while MGNX’s TA Score has 3 bullish TA indicator(s).

  • AMRN’s TA Score: 2 bullish, 6 bearish.
  • MGNX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, MGNX is a better buy in the short-term than AMRN.

Price Growth

AMRN (@Pharmaceuticals: Major) experienced а -2.63% price change this week, while MGNX (@Biotechnology) price change was -11.05% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -0.46%. For the same industry, the average monthly price growth was -0.13%, and the average quarterly price growth was +11.03%.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.28%. For the same industry, the average monthly price growth was +6.08%, and the average quarterly price growth was +34.58%.

Reported Earning Dates

MGNX is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-0.46% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

@Biotechnology (+1.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMRN($309M) has a higher market cap than MGNX($92.9M). AMRN YTD gains are higher at: 50.515 vs. MGNX (-52.923). MGNX has higher annual earnings (EBITDA): -26.91M vs. AMRN (-70.12M). AMRN has more cash in the bank: 299M vs. MGNX (176M). AMRN has less debt than MGNX: AMRN (7.34M) vs MGNX (37.2M). AMRN has higher revenues than MGNX: AMRN (219M) vs MGNX (164M).
AMRNMGNXAMRN / MGNX
Capitalization309M92.9M333%
EBITDA-70.12M-26.91M261%
Gain YTD50.515-52.923-95%
P/E RatioN/AN/A-
Revenue219M164M134%
Total Cash299M176M170%
Total Debt7.34M37.2M20%
FUNDAMENTALS RATINGS
AMRN vs MGNX: Fundamental Ratings
AMRN
MGNX
OUTLOOK RATING
1..100
7167
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
79
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9698
PRICE GROWTH RATING
1..100
4364
P/E GROWTH RATING
1..100
10095
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MGNX's Valuation (79) in the Biotechnology industry is in the same range as AMRN (90) in the Pharmaceuticals Other industry. This means that MGNX’s stock grew similarly to AMRN’s over the last 12 months.

MGNX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as AMRN (100) in the Pharmaceuticals Other industry. This means that MGNX’s stock grew similarly to AMRN’s over the last 12 months.

AMRN's SMR Rating (96) in the Pharmaceuticals Other industry is in the same range as MGNX (98) in the Biotechnology industry. This means that AMRN’s stock grew similarly to MGNX’s over the last 12 months.

AMRN's Price Growth Rating (43) in the Pharmaceuticals Other industry is in the same range as MGNX (64) in the Biotechnology industry. This means that AMRN’s stock grew similarly to MGNX’s over the last 12 months.

MGNX's P/E Growth Rating (95) in the Biotechnology industry is in the same range as AMRN (100) in the Pharmaceuticals Other industry. This means that MGNX’s stock grew similarly to AMRN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRNMGNX
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
N/A
Bullish Trend 14 days ago
83%
Declines
ODDS (%)
Bearish Trend 8 days ago
87%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
82%
Aroon
ODDS (%)
Bearish Trend 7 days ago
90%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AIRRF0.750.01
+1.31%
Aurion Resources Ltd.
BCLYF5.180.05
+1.07%
Barclays Plc
RAFLF0.80N/A
N/A
Raffles Medical Group Ltd.
TMICF58.29N/A
N/A
Trend Micro Inc.
IHLDF0.11N/A
-1.16%
Immutable Holdings Inc.